The FDA has given the green light for Teva's new monthly shot for treating schizophrenia.

Oct 9, 2026, 12:39 PM ETTrialRead the original at Benzinga

Good for TEVA

FDA approval lets Teva sell Weltruza in the U.S., and Phase 3 results showed improvements in symptoms and social functioning. U.S. sales are planned in coming weeks, so sales benefits are not yet shown.

TEVA · Teva Pharmaceutical Industries Ltd.

AI read · Good for TEVA

The AI's read

A monthly dose may help patients who struggle to take daily pills, giving Teva a useful new treatment. Phase 3 results support its use. The launch is still weeks away, so the story gives no sales figures yet.

Get alerts for TEVA

Follow Teva Pharmaceutical Industries Ltd. (TEVA) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for TEVA

Free on the App Store and Google Play, or on the web.